Patent: 4,737,462
✉ Email this page to a colleague
Summary for Patent: 4,737,462
Title: | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-.beta. |
Abstract: | A modified IFN-.beta. is provided wherein the cysteine residue at position 17 is deleted and serine is substituted therefor. DNA sequences coding for the modified protein, nucleotide primers used for the mutagenesis, appropriate cloning vectors, host organisms transformed with the vectors, methods for the production and use of the modified IFN-.beta. (IFN-.beta..sub.ser17) are also provided. The specific activity of IFN-.beta..sub.ser17 is found to be substantially the same as that of native IFN-.beta.. |
Inventor(s): | Mark; David F. (Hercules, CA), Lin; Leo S. (Fremont, CA), Yu Lu; Shi-Da (Oakland, CA) |
Assignee: | Cetus Corporation (Emeryville, CA) |
Application Number: | 06/753,717 |
Patent Claims: | see list of patent claims |
Details for Patent 4,737,462
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Bayer Healthcare Pharmaceuticals Inc. | BETASERON | interferon beta-1b | For Injection | 103471 | July 23, 1993 | ⤷ Sign Up | 2005-04-12 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 4,737,462
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 33503 | ⤷ Sign Up |
Austria | 46539 | ⤷ Sign Up |
Austria | 61407 | ⤷ Sign Up |
Austria | 73493 | ⤷ Sign Up |
Australia | 2008683 | ⤷ Sign Up |
Australia | 563962 | ⤷ Sign Up |
Belgium | 898016 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |